A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : aCML / atypical chronic myeloid leukemia

[Related PubMed/MEDLINE]
Total Number of Papers: 77
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   aCML  (>> Co-occurring Abbreviation)
Long Form:   atypical chronic myeloid leukemia
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia. HMAs, LDH, VAFs
2020 A rare atypical chronic myeloid leukemia BCR-ABL1 negative with concomitant JAK2 V617F and SETBP1 mutations: a case report and literature review. MDS/MPN
2020 Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial Presentation. AP, MDS/MPN
2020 CSF3R truncation mutations in a patient with B-cell acute lymphoblastic leukemia and a favorable response to chemotherapy plus dasatinib. ALL, CNL, CSF3R
2020 Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib. MDS
2020 Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms. MDS/MPN, Ph
2020 Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes. CMML, JMML, MDS, MDS-RS, MPN
2020 Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia. ---
2020 Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review. CMML, JMML, MDS, MPN
10  2019 Atypical chronic myeloid leukemia achieving good response with azacitidine. AZA, HSCT, HU
11  2019 Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review. ---
12  2019 Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia. CMML
13  2019 Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL). CLL
14  2019 Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. CNL, CR, CSF3R, ORR, PR
15  2019 Genomic landscape of neutrophilic leukemias of ambiguous diagnosis. CNL
16  2019 Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia. ---
17  2019 [MYC gene amplification attributed to double minutes in a patient with atypical chronic myeloid leukemia]. dmin
18  2018 Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan. allo-HSCT, CI, CNL, OS
19  2018 Atypical chronic myeloid leukaemia - arare subtype of myelodysplastic/myeloproliferative neoplasm. ---
20  2018 Atypical chronic myeloid leukaemia: A case of an orphan disease-A multicenter report by the Polish Adult Leukemia Group. ---
21  2018 Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia. CMML
22  2018 Current and evolving understanding of atypical chronic myeloid leukemia. HSCT, MDS
23  2018 Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia. MDS, sAML
24  2018 Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia. ---
25  2017 Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. allo-HSCT, EBMT, HLA, MUD, NRM
26  2017 Atypical chronic myeloid leukemia in a German Shepherd Dog. ---
27  2017 Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report. idicX, iX, MDS/MPN
28  2017 Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, in a 5-Month Baby - ARare Presentation. CML
29  2017 Atypical chronic myeloid leukemia: a rare entity with management challenges. ---
30  2017 Identification of a novel CSF3R-SPTAN1 fusion gene in an atypical chronic myeloid leukemia patient with t(1;9)(p34;q34) by RNA-Seq. CNL, CSF3R, HSCT, RT-PCR, SPTAN1
31  2017 Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. CNL, WHO
32  2017 SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome. CMML, JMML, MDS, MPN
33  2017 Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. OS
34  2016 An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T. CMML, JMML, MDS/MPN, RARS-T, WHO
35  2016 Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes. CMML, JMML, RARS-T
36  2016 Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases. DCA
37  2016 Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia. CNL, CSF3R
38  2016 [Inhibitory effect of RNA interference targeting GFI-1 on the proliferation of atypical chronic myelogenous leukemia NT1 cells]. qRT-PCR
39  2016 [Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia]. ---
40  2015 Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice. CMML, CNL
41  2015 Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature. ---
42  2015 Morgana acts as an oncosuppressor in chronic myeloid leukemia. BM
43  2015 Reassessment of H&E stained clot specimens and immunohistochemistry of phosphorylated Stat5 for histological diagnosis of MDS/MPN. CMML, JMML, MDS, MDS/MPN
44  2015 The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I. CNL, CSF3R
45  2015 What's different about atypical CML and chronic neutrophilic leukemia? CNL
46  2014 Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. MDS/MPN
47  2014 I walk the other line: myelodysplastic/myeloproliferative neoplasm overlap syndromes. CMML, MDS/MPN, RARS-T
48  2014 Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases. NGS, RT-PCR
49  2014 Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable. CMML, JMML, MDS/MPN, RARS-T
50  2014 Recurrent ETNK1 mutations in atypical chronic myeloid leukemia. ---
51  2014 Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia. CNL, CSF3R
52  2014 [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia]. CNL
53  2013 Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms. CMML, HCT, MAC, MDS/MPN, RIC
54  2013 SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. MDSs, MPNs, SETBP1, SETBP1mut
55  2013 Somatic SETBP1 mutations in myeloid malignancies. CMML, MDS, sAML, SGS
56  2012 Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions. CMML, MDS/MPN
57  2012 Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. CI
58  2010 [Clinical pathological features of the 8p11 myeloproliferative syndrome]. CMML, FGFR1, RT-PCR, T-LBL
59  2009 The finding of a reciprocal whole-arm translocation t(X;12)(p10;p10) in association with atypical chronic myeloid leukaemia. WAT
60  2009 The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia. BM, CGL-CP, CMML, PB
61  2008 Abnormal chromatin clumping in leucocytes of Ph positive chronic myeloid leukemia cases - extending the morphological spectrum. WHO
62  2008 Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm. BM, cMPN, Ph
63  2007 A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy. SPTBN1
64  2006 Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology. CMML
65  2005 The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. ALL, AML, CLL, CMML, JAK2, MDS, MPDs
66  2004 A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate. ---
67  2004 Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia. HSCT, PCR
68  2004 Two clonal occurrences of tetrasomy 21 in an atypical chronic myeloid leukemia with wild-type RUNX1 alleles. Additional support for a gene dosage effect of chromosome 21 or RUNX1 in leukemia. ---
69  2002 Translocation t(9;22) (p23;q11) in atypical chronic myeloid leukemia (aCML) presenting osteolytic lesions. FISH, PTH
70  2002 [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders]. CMML, CNL
71  2000 Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia. CMML, FISH
72  1999 A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features. ---
73  1999 New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia. CFU-GM
74  1996 Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome? CGL, CMML
75  1996 Mixed myelodysplastic and myeloproliferative syndromes. AML, MDS, MDS-MPS, MPD
76  1991 Cross-lineage rearrangement of antigen receptor genes in atypical chronic myeloid leukemia. bcr, Ig, TCR
77  1990 Trisomy 14 in atypical chronic myeloid leukemia. M-bcr